• español
    • English
    • português
  • English 
    • español
    • English
    • português
  • IRIS PAHO Home
  • PAHO website
  • Indexes
  • All Collections
  • About IRIS
  • Institutional Memory
  • Our Newsletter
  • Contact
JavaScript is disabled for your browser. Some features of this site may not work without it.
View Item 
  •   IRIS PAHO Home
  • 1.PAHO Headquarters / Sede de la OPS
  • Scientific Journals and Newsletters / Revistas Científicas y Boletines
  • Pan American Journal of Public Health
  • View Item
  •   IRIS PAHO Home
  • 1.PAHO Headquarters / Sede de la OPS
  • Scientific Journals and Newsletters / Revistas Científicas y Boletines
  • Pan American Journal of Public Health
  • View Item

Normas para la publicación de investigaciones clínicas patrocinadas por la industria farmacéutica

Thumbnail
View/Open
16644.pdf (52.10Kb)
Date
2003
Author
Anon
Metadata
Show full item record

Abstract
The role played by the private sector, in particular the pharmaceutical industry, in funding research has been growing at an accelerated pace in recent decades. So much so, in fact, that the private sector has become the primary funding source of clinical trials in some countries. As a result, pharmaceutical companies exercise ever-growing control over not only the design of clinical trials but also the publication of their results. The conflicts of interest involved in this kind of situation can lead to ethical breaches (for example, suppression or distortion of results or the intimidation of investigators), and it is crucial to take concrete steps to guard against such breaches. This is exactly what a Working Group made up of members of the pharmaceutical industry itself has done, preparing a series of guidelines for that industry in order to promote good publication practices. These guidelines, which were just recently published in English, represent an important step in efforts to achieve greater transparency and accountability in the presentation of results of research funded by manufacturers of pharmaceutical products. Although the guidelines, now translated into Spanish in this piece, are subject to future revisions, they are a valuable starting point for further discussion of a problem that deserves the urgent attention of the scientific community (AU)
Translated title
Publication standards for clinical research sponsored by the pharmaceutical industry
Series
Rev Panam Salud Publica;14(1),jul. 2003
URI
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003000600018&lng=pt&nrm=iso&tlng=es
https://iris.paho.org/handle/10665.2/8472
Citation
Anon (2003) Normas para la publicación de investigaciones clínicas patrocinadas por la industria farmacéutica. Rev Panam Salud Publica;14(1) 62-66,jul. 2003. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003000600018&lng=pt&nrm=iso&tlng=es
Collections
  • Pan American Journal of Public Health

Browse

All of IRIS PAHOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsSeries TitleType of materialLanguageCategoryThis CollectionBy Issue DateAuthorsTitlesSubjectsSeries TitleType of materialLanguageCategory

Statistics

View Usage Statistics

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663
email: libraryhq@paho.org

Links

  • PAHO Featured Publications
  • WHO Digital Library (IRIS)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)